GLADSTONE AIREWELE to Multicenter Studies as Topic
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Multicenter Studies as Topic.
Connection Strength
0.080
-
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538.
Score: 0.052
-
Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am J Hematol. 2015 Jan; 90(1):2-7.
Score: 0.028